Stockreport

Moderna Announces IND Submitted to U.S. FDA for Phase 2 Study of mRNA Vaccine (mRNA-1273) Against Novel Coronavirus

Moderna, Inc.  (MRNA) 
Last moderna, inc. earnings: 2/26 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: marinabio.com/investor-relations
PDF 600 participant Phase 2 study to begin upon IND acceptance and safety data from ongoing NIH-led Phase 1 studyPlanning underway for Phase 3 study; study expected to begin [Read more]